PAMU
VIR icon

Pictet Asset Management (UK)’s Vir Biotechnology VIR Stock Holding History

Pictet Asset Management (UK)’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$201K Buy
+4,251
New +$193K ﹤0.01% 1644

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Pictet Asset Management (UK)'s VIR Position: Q2 2021 in Review

Pictet Asset Management (UK) opened a new position in Vir Biotechnology (VIR) in Q2 2021: 4,251 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #1644 among its holdings.

166 funds tracked by Wall St. Rank hold VIR as of Q2 2021.

  • Pictet Asset Management (UK) held 4,251 shares of Vir Biotechnology worth $201K as of Q2 2021.
  • Vir Biotechnology was a new Pictet Asset Management (UK) position in Q2 2021.
  • Vir Biotechnology made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1644 holding.
  • 166 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.